Broughton Partners is a great team to work with, and they always deliver as promised. Their communication and ability to adapt to changes and events have always been impressive in our joint ventures with them. I highly recommend Broughton Partners.
On Wednesday, March 20, 2019, the United States Food and Drug Administration (FDA) sent letters of warning to two manufacturers […]
Adverse events involving staples for internal use, as well as external surgical staplers, have been increasing by significant numbers. This […]